Carregant...

Tocilizumab in rheumatoid arthritis: efficacy, safety and its place in therapy

Tocilizumab is a humanized antihuman interleukin-6 (IL-6) receptor monoclonal antibody. It was developed in Japan as the first biological disease-modifying antirheumatic drug targeting IL-6 receptors. Many large-scale global studies have demonstrated its efficacy and safety, and in April 2008 it was...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Kaneko, Atsushi
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3539265/
https://ncbi.nlm.nih.gov/pubmed/23342244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622312466908
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!